279 related articles for article (PubMed ID: 33577036)
1. Effects of PPARγ agonist pioglitazone on cardiac fibrosis in diabetic mice by regulating PTEN/AKT/FAK pathway.
Zhang XD; Sun GX; Guo JJ; Hu CC; Sun RC; Yu HC
Eur Rev Med Pharmacol Sci; 2021 Jan; 25(2):812-819. PubMed ID: 33577036
[TBL] [Abstract][Full Text] [Related]
2. ANO1 relieves pressure overload-induced myocardial fibrosis in mice by inhibiting TGF-β/Smad3 signaling pathway.
Kong JC; Miao WQ; Wang Y; Zhou SF
Eur Rev Med Pharmacol Sci; 2020 Aug; 24(16):8493-8501. PubMed ID: 32894555
[TBL] [Abstract][Full Text] [Related]
3. Effect of IL-6-mediated STAT3 signaling pathway on myocardial apoptosis in mice with dilated cardiomyopathy.
Li Q; Ye WX; Huang ZJ; Zhang Q; He YF
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):3042-3050. PubMed ID: 31002169
[TBL] [Abstract][Full Text] [Related]
4. Cardioprotective effect of pioglitazone and curcumin against diabetic cardiomyopathy in type 1 diabetes mellitus: impact on CaMKII/NF-κB/TGF-β1 and PPAR-γ signaling pathway.
Gbr AA; Abdel Baky NA; Mohamed EA; Zaky HS
Naunyn Schmiedebergs Arch Pharmacol; 2021 Feb; 394(2):349-360. PubMed ID: 32984914
[TBL] [Abstract][Full Text] [Related]
5. The PPARγ agonist pioglitazone prevents TGF-β induced renal fibrosis by repressing EGR-1 and STAT3.
Németh Á; Mózes MM; Calvier L; Hansmann G; Kökény G
BMC Nephrol; 2019 Jul; 20(1):245. PubMed ID: 31277592
[TBL] [Abstract][Full Text] [Related]
6. Urocortin attenuates myocardial fibrosis in diabetic rats via the Akt/GSK-3β signaling pathway.
Liu X; Liu C; Li J; Zhang X; Song F; Xu J
Endocr Res; 2016 May; 41(2):148-57. PubMed ID: 26934363
[TBL] [Abstract][Full Text] [Related]
7. Stimulation of Peroxisome Proliferator-Activated Receptor-Gamma (PPARγ) using Pioglitazone Decreases the Survival of Acute Promyelocytic Leukemia Cells through Up-Regulation of PTEN Expression.
Esmaeili S; Safaroghli-Azar A; Pourbagheri-Sigaroodi A; Salari S; Gharehbaghian A; Hamidpour M; Bashash D
Anticancer Agents Med Chem; 2021; 21(1):108-119. PubMed ID: 32807067
[TBL] [Abstract][Full Text] [Related]
8. [Mechanism of reversion of myocardial interstitial fibrosis in diabetic cardiomyopathy by valsartan].
Zhong M; Zhang Y; Miao Y; Li L; Gong HP; Ma X; Sun H; Zhang W
Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(4):232-6. PubMed ID: 16677501
[TBL] [Abstract][Full Text] [Related]
9. LncRNA NEAT1 alleviates sepsis-induced myocardial injury by regulating the TLR2/NF-κB signaling pathway.
Wang SM; Liu GQ; Xian HB; Si JL; Qi SX; Yu YP
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4898-4907. PubMed ID: 31210324
[TBL] [Abstract][Full Text] [Related]
10. Microarray profiling analysis identifies the mechanism of miR-200b-3p/mRNA-CD36 affecting diabetic cardiomyopathy via peroxisome proliferator activated receptor-γ signaling pathway.
Xu L; Chen W; Ma M; Chen A; Tang C; Zhang C; Cai L
J Cell Biochem; 2019 Apr; 120(4):5193-5206. PubMed ID: 30506990
[TBL] [Abstract][Full Text] [Related]
11. Effect of alprostadil on myocardial fibrosis in rats with diabetes mellitus via TGF-β1/Smad signaling pathway.
Tu JH; Xu Y; Dai Y; Dang L
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(21):9633-9641. PubMed ID: 31773714
[TBL] [Abstract][Full Text] [Related]
12. Peroxisome proliferator-activated receptor-gamma activation attenuates diabetic cardiomyopathy via regulation of the TGF-β/ERK pathway and epithelial-to-mesenchymal transition.
Yan XL; Wang YY; Yu ZF; Tian MM; Li H
Life Sci; 2018 Nov; 213():269-278. PubMed ID: 30189217
[TBL] [Abstract][Full Text] [Related]
13. Curcumin alleviates diabetic cardiomyopathy in experimental diabetic rats.
Yu W; Wu J; Cai F; Xiang J; Zha W; Fan D; Guo S; Ming Z; Liu C
PLoS One; 2012; 7(12):e52013. PubMed ID: 23251674
[TBL] [Abstract][Full Text] [Related]
14. Scutellarin protects against diabetic cardiomyopathy via inhibiting oxidative stress and inflammatory response in mice.
Xu L; Chen R; Zhang X; Zhu Y; Ma X; Sun G; Sun X
Ann Palliat Med; 2021 Mar; 10(3):2481-2493. PubMed ID: 33549002
[TBL] [Abstract][Full Text] [Related]
15. Pioglitazone downregulates Twist-1 expression in the kidney and protects renal function of Zucker diabetic fatty rats.
Wang Z; Liu Q; Dai W; Hua B; Li H; Li W
Biomed Pharmacother; 2019 Oct; 118():109346. PubMed ID: 31506251
[TBL] [Abstract][Full Text] [Related]
16. Theacrine attenuates myocardial fibrosis after myocardial infarction via the SIRT3/β-catenin/PPARγ pathway in estrogen-deficient mice.
Song LL; Zhang Y; Zhang XR; Song YN; Dai HZ
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5477-5486. PubMed ID: 31298401
[TBL] [Abstract][Full Text] [Related]
17. Effects of miR-21 on hypertensive rats through PTEN/PI3K/Akt/mTOR signaling pathway.
Shi YJ; Xu W; Han YF; Li JX; Niu LL; Chen YD
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4924-4931. PubMed ID: 31210327
[TBL] [Abstract][Full Text] [Related]
18. Effect of miR-26a on diabetic rats with myocardial injury by targeting PTEN.
Cai SS; Tao XW; Long Y; Xia K; Zhang Y
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):304-311. PubMed ID: 31389595
[TBL] [Abstract][Full Text] [Related]
19. Exercise Prevents Cardiac Injury and Improves Mitochondrial Biogenesis in Advanced Diabetic Cardiomyopathy with PGC-1α and Akt Activation.
Wang H; Bei Y; Lu Y; Sun W; Liu Q; Wang Y; Cao Y; Chen P; Xiao J; Kong X
Cell Physiol Biochem; 2015; 35(6):2159-68. PubMed ID: 25896313
[TBL] [Abstract][Full Text] [Related]
20. A peroxisome proliferator-activated receptor gamma agonist attenuates neurological deficits following spinal cord ischemia in rats.
Kim H; Hwang J; Park S; Nahm SF; Min S; Lim C; Park K; Han S
J Vasc Surg; 2014 Apr; 59(4):1084-9. PubMed ID: 23830318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
